Votre recherche pour: 2,3,6-Trifluorobenzald\u00E9hyde

Numéro de catalogue: (115-1615)

Fournisseur: Essity

Description: Ces distributeurs de rouleaux à dévidage central permettent une manipulation facile, d'une seule main, et délivrent la quantité de papier souhaitée. Ils sont parfaits pour les zones nécessitant l'essuyage des mains et de petites surfaces, comme les laboratoires de préparation alimentaire.

UOM: 1 * 1 ST

Promotion

Numéro de catalogue: (390-0999)

Fournisseur: VWR Collection

Description: Les incubateurs numériques IL 10, IL 23 et IL 56 constituent une solution économique et peu encombrante pour les applications de microbiologie ou d’hématologie. La température peut être réglée par incréments de 0,1 °C jusqu’à un maximum de 70 °C. Les éléments chauffants sont incorporés dans la base et sur les parois du boîtier pour garantir une température stable et uniforme. L’IL 10 est disponible avec une fenêtre en Plexiglas® transparent pour une visibilité totale ou une fenêtre peinte en Plexiglas® opaque pour protéger les échantillons photosensibles. IL 23 et IL 56 sont équipés par défaut d’une fenêtre en Plexiglas® transparent. Le boîtier et l’encadrement de la porte sont entièrement construits en acier doux revêtu d’époxy.

UOM: 1 * 1 ST

Certificats Promotion

Numéro de catalogue: (BOSSBS-9500R-CY5.5)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (BOSSBS-9500R-HRP)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (EHERC17883600)

Fournisseur: EHRENSTORFER

Description: 2,3,6-Triméthylphénol

UOM: 1 * 0,25 g

Promotion

Numéro de catalogue: (EHERC17773600)

Fournisseur: EHRENSTORFER

Description: 2,3,6-Trichlorophénol

UOM: 1 * 0,1 g

Promotion

Numéro de catalogue: (LBCP3971830)

Fournisseur: LABCONCO

Description: XPert™ balance enclosures provide user protection by keeping powders, particulates and fume contained during weighing procedures. They are well suited for pharmaceutical research and other laboratory applications involving weighing of toxic substances. These vented balance safety enclosures may be ducted to the outside or connected to the FilterMate Portable Exhauster to be exhausted back into the laboratory through HEPA filters, carbon filters, or a combination of both HEPA and carbon filters.

UOM: 1 * 1 ST

Promotion

Numéro de catalogue: (BOSSBS-9500R-A680)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation. Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesised in the liver and circulates as an inactive precursor. Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds. Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease.

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (BOSSBS-9500R-CY7)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (BOSSBS-9500R-A555)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (BOSSBS-9500R-A350)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (BOSSBS-9500R-CY5)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Fournisseur: Apollo Scientific

Description: Vancomycin is a glycopeptide antibiotic. It exerts its action by inhibiting the formation of the peptidoglycan polymers of the bacterial cell wall. Often used incombination with cefotaxim or carbenicillin.

Numéro de catalogue: (EHERC17713600)

Fournisseur: EHRENSTORFER

Description: 2,3,6-Trichloroanisole

UOM: 1 * 0,1 g

Promotion

Numéro de catalogue: (BOSSBS-9500R-A488)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promotion

Numéro de catalogue: (BOSSBS-9500R-A750)

Fournisseur: Bioss

Description: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation. Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesised in the liver and circulates as an inactive precursor. Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds. Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease.

UOM: 1 * 100 µl

Promotion